Skip to content

Released Nov 9, 2016, after the close

10-Q filed Nov 9, 2016, 40 days after period end · 0001390478-16-000164

Q3 2016 · 10-Q
Revenue—
Net Income-$6.93Mno prior Q3 2015 on fileN/M vs Q2 2016
EPS, diluted—
Operating Income-$6,472,000—
Operating Cash Flowderived-$12,208,000—
Free Cash Flowderived-$12,208,000—

What the release said

No earnings release is on file for this quarter. Its figures came with the 10-Q.

Same quarter

MetricQ3 2016Q3 2013Q3 2012Q3 2011
Revenue—$2.17M$2.17M—
Net Income-$6.93M-$6.93M-$18.03M-$5.48M
EPS Diluted—-$0.11-$0.09-$0.14

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

SELLAS Life Sciences Group, Inc. · CIK 1390478 · Engraved from SEC EDGAR